Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract (Q40158643)
scientific article published on 20 February 2007
Language:
(P31) (Q13442814)
(P50) (Q87989050)
(Q115615994)
(Q115616019)
(P304) 652-665
(P407) (Q1860)
(P433) 3
(P478) 368
(P577) Tuesday, February 20, 2007
(P921) (Q1052913)
(Q128406)
(P1433) (Q925779)
(P1476) "Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract" (language: en)
(P2093) David S Pfarr
Syd Johnson
Yambasu A Brewah
Robert M Woods
Wendy I White
James F Young
(P2860) (Q34341948)
(Q45752849)
(Q50653027)
(Q45759631)
(Q29307662)
(Q40419286)
(Q36105050)
(Q77183363)
(Q37914133)
(Q39652266)
(Q35562475)
(Q44603480)
(Q41098585)
(Q35871741)
(Q45844009)
(Q43927324)
(Q45764623)
(Q29615578)
(Q45757638)
(Q67711120)
(Q45604589)
(Q27486621)
(Q115920273)
(Q24246151)
other details
description scientific article published on 20 February 2007

External Links